Delta-like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overview.

Cancer Science
Kentaro MatsuoKazuhisa Uchiyama

Abstract

Delta-like canonical Notch ligand 3 (DLL3) is a member of the Delta/Serrate/Lag2 (DSL) Notch receptor ligand family and plays a crucial role in Notch signaling, which influences various cellular processes including differentiation, proliferation, survival, and apoptosis. DLL3 is expressed throughout the presomitic mesoderm and is localized to the rostral somatic compartments; mutations in DLL3 induce skeletal abnormalities such as spondylocostal dysostosis. Recently, DLL3 has attracted interest as a novel molecular target due to its high expression in neuroendocrine carcinoma of the lung. Moreover, a DLL3-targeting Ab-drug conjugate, rovalpituzumab tesirine (ROVA-T), has been developed as a new treatment with proven antitumor activity. However, the development of ROVA-T was suspended because of shorter overall survival compared to topotecan, the second-line standard treatment. Thus, several studies on the mechanism and function of DLL3 in several malignancies are underway to find a new strategy for targeting DLL3. In this review, we discuss the roles of DLL3 in various malignancies and the future perspectives of DLL3-related research, especially as a therapeutic target.

References

Jul 30, 1993·International Journal of Cancer. Journal International Du Cancer·T FujiwaraT Nagatsu
Nov 12, 1998·Acta neurochirurgica·T IuchiA Yamaura
Oct 23, 2003·Nature Reviews. Cancer·Freddy Radtke, Kenneth Raj
Feb 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ayyakannu AyyananCathrin Brisken
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
Aug 1, 2007·The Journal of Cell Biology·Insa GeffersAchim Gossler
Sep 2, 2008·Oncogene·B D'SouzaG Weinmaster
Sep 6, 2008·Science·D Williams ParsonsKenneth W Kinzler
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
Feb 26, 2009·Cell·Andrea Ventura, Tyler Jacks
Mar 5, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael E MullendoreGeorg Feldmann
Oct 14, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fan WuChun Fan
Oct 9, 2012·Seminars in Oncology·Elie FahedTanya B Dorff
Jan 23, 2013·International Journal of Oncology·Kentaro MaemuraYoshinori Otsuki
Oct 1, 2014·Proceedings of the National Academy of Sciences of the United States of America·Alexander AugustynJohn D Minna
Sep 12, 2015·Lancet·Philippe MoriceEmile Darai
Dec 5, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ColomboUNKNOWN ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group
Dec 23, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Robert M Frederickson
Mar 1, 2016·Archives of Medical Science : AMS·Paweł GutMarek Ruchała
Dec 23, 2016·Biochemical and Biophysical Research Communications·San-Ming DengHua Han
Jul 15, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jianpeng WangYazhuo Zhang
Mar 21, 2018·Scientific Reports·Hiroki HamamotoKazuhisa Uchiyama
Apr 19, 2018·Current Pharmaceutical Biotechnology·Androulla N Miliotou, Lefkothea C Papadopoulou
Oct 1, 2018·Clinical Breast Cancer·Semir VranicZoran Gatalica
Oct 18, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Vadim S KoshkinPetros Grivas
Nov 7, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marissa SpinoAndrew S Chi
Mar 16, 2019·Cancer Science·Megumi FurutaJun Sakakibara-Konishi
Mar 22, 2019·Science Translational Medicine·Loredana PucaHimisha Beltran
May 10, 2019·The Oncologist·Megumi FurutaUNKNOWN Hokkaido Lung Cancer Clinical Study Group
Jun 20, 2019·Journal of Hematology & Oncology·Dwight H OwenKai He
Sep 12, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel MorgenszternDavid P Carbone
Jan 26, 2020·EBioMedicine·Yoshitaka IsobeYoshinori Hasegawa
May 7, 2020·The Oncologist·Hao XieAaron S Mansfield
Nov 19, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael J GiffinPaul E Hughes
Feb 20, 2021·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Fiona BlackhallNiels Reinmuth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Federico RojoFrédérique Penault-Llorca
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Kentaro TanakaIsamu Okamoto
© 2021 Meta ULC. All rights reserved